The Promise of Discovery

The research discussed in this episode focuses on how low doses of the drug ketamine produce fast and long-term antidepressant effects and identifies the gene (MeCP2) and processes in the brain that are involved. 

VKC Researcher: Lisa Monteggia, Ph.D., Barlow Family Director of the Vanderbilt Brain Institute; Professor of Pharmacology

Interviewer: Jeffrey L. Neul, M.D., Ph.D., Annette Schaffer Eskind Chair and Director, Vanderbilt Kennedy Center; Professor of Pediatrics, Division of Neurology, Pharmacology, and Special Education

What is The Promise of Discovery?

“The Promise of Discovery” is a podcast hosted by the Vanderbilt Kennedy Center that highlights research in intellectual and developmental disabilities. The goals of the podcast are to host conversations about research in plain language and to highlight “real world” implications. The discussions cover why the research matters in the lives of people with disabilities and families, how the research impacts and enhances what we know already and/or raises additional questions in the field, and what implications the research might have for policy.